Aug 2026· Medical Oncology· Vol 43· 0 citations· 85 references
Medicine
TL;DR
A deeper mechanistic understanding of HOX-driven networks will aid the development of innovative biomarkers and therapies, thereby advancing precision medicine in endocrine oncology, and advancing precision medicine in endocrine oncology.
Epigenetics plays a central role in cancer development and progression by governing the expression of genes involved in these processes. Accumulating evidence strongly indicates that these mechanisms not only alter cancer cell‐intrinsic properties but also mediate reciprocal interactions between cancer cells and the tu...
Ji Hoon Park, Mi-Young Kim· Molecular Oncology· 0 citations
Snail2 (SNAI2/Slug), a core C2H2 zinc-finger transcription factor of the Snail superfamily, functions as a master regulator of epithelial-mesenchymal transition (EMT) and cellular plasticity in development and disease. Unlike other EMT transcription factors that drive complete transition, Snail2 distinctively promote...
Yi-Meng Chen, Zheng-Lin He, Yi-Ping Jiao et al.· Cell Death Discovery· 0 citations
ESRRB is an essential orphan nuclear receptor in embryonic development and in the maintenance of pluripotency. It can contribute to the self-renewal capacity of embryonic stem cells by regulating gene networks involved in cell fate decisions, influenced by core transcription factors such as NANOG, SOX2 and OCT4. Mech...
Emma Rocaboy, Shiva Ghadiri, Yoshiaki Tanaka· Clinical and Experimental Me...· 0 citations
Tumor-promoting myofibroblastic carcinoma-associated fibroblasts (myCAFs) are induced by activation of transforming growth factor-β (TGF-β) signaling. However, the molecular basis of myCAF-specific transcriptional programs regulated by TGF-β signaling remains poorly understood. Using a meta-analysis of single-cell RNA-...